64x Bio
ActiveEnabling next generation medicines. A comprehensive platform and…
What it does
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.
Its site says now · captured 2026-08-23
64x | Enabling next generation medicines
Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufacturing. Expert solutions for gene therapies and scalable bioengineering.
Next to it in Healthcare and bio · Cell line engineering and biomanufacturing
- ReactosomeSOSV SOSV IndieBio SF 15
Synthetic cell platform
- Meccellis BiotechPlug and Play
Meccellis Biotech specializes in tissue and cell engineering.
- ShiruY Combinator S19
Shiru leverages ML to create proteins to feed the world sustainably.
- Dropprint GenomicsY Combinator W20
The better way to run single cell genomics
- Protera BiosciencesSOSV SOSV IndieBio 04
Smarter proteins for a sustainable future
- Trident BioscienceY Combinator S20
Accelerating protein engineering.
- CellChorusY Combinator S21
The dynamic single-cell analysis company
- CYBOPlug and Play
CYBO provides products and services to understand cells deeply and to harness them widely.